This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
The buyout, announced last summer, drew the attention of federal regulators at the Federal Trade Commission, concerned that competition for ambulatory surgery services would be stifled by the merger. To appease the agency, Ascension has agreed to divest from some centers previously owned by Amsurg.
AI is now as much a part of U.S. healthcare as any other technology category in wide use across the sector. However, like no other technology, its role is “being actively shaped, not passively adopted” by clinicians and patients alike.
A recent OIG report suggested vascular surgeons, interventional cardiologists and interventional radiologists may be performing medically unnecessary procedures in office-based labs. Now, some of the leading medical societies from those fields have provided additional context.
Researchers from Brigham and Women's Hospital and Harvard Medical School compared 89 generic drugs sold by Mark Cuban Cost Plus Drug Company (MCCPDC) to what Medicare paid for the same drugs in 2020.
While a vast majority of heart transplants in the United States are successful, unplanned hospitalizations after the procedures are still incredibly common.
When the ongoing contrast media shortage first started impacting health systems, one group in Ohio pledged not to delay a single procedure in its cath labs.
The court case stems from HHS’ 2018 final rule establishing separate reimbursement rates for hospitals that serve low-income or rural populations through the 340B program and all other hospitals.